KR950700305A - 칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists) - Google Patents
칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists)Info
- Publication number
- KR950700305A KR950700305A KR1019940702589A KR19940702589A KR950700305A KR 950700305 A KR950700305 A KR 950700305A KR 1019940702589 A KR1019940702589 A KR 1019940702589A KR 19940702589 A KR19940702589 A KR 19940702589A KR 950700305 A KR950700305 A KR 950700305A
- Authority
- KR
- South Korea
- Prior art keywords
- calcium channel
- channel antagonists
- azabicyclo compounds
- azabicyclo
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201751A GB9201751D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
PCT/GB1993/000174 WO1993015080A1 (en) | 1992-01-28 | 1993-01-27 | Azabicyclo compounds as calcium channel antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950700305A true KR950700305A (ko) | 1995-01-16 |
Family
ID=10709351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940702589A KR950700305A (ko) | 1992-01-28 | 1994-07-27 | 칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists) |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0625981A1 (ko) |
JP (1) | JPH07503462A (ko) |
KR (1) | KR950700305A (ko) |
AU (1) | AU3364593A (ko) |
CA (1) | CA2128536A1 (ko) |
GB (1) | GB9201751D0 (ko) |
MX (1) | MX9300406A (ko) |
WO (1) | WO1993015080A1 (ko) |
ZA (1) | ZA93549B (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
US6251919B1 (en) | 1998-02-27 | 2001-06-26 | Warner-Lambert | Heterocyclic substituted aniline calcium channel blockers |
US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
SK8002003A3 (en) | 2000-12-22 | 2004-05-04 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as M3 antagonists |
ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
ES2204295B1 (es) | 2002-07-02 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de quinuclidina-amida. |
US8114891B2 (en) | 2007-10-01 | 2012-02-14 | Comentis, Inc. | 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof |
TW201617342A (zh) | 2014-07-11 | 2016-05-16 | 阿法馬根公司 | 調節α7活性之啶類 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1250534A (ko) * | 1969-03-03 | 1971-10-20 | ||
GB9005737D0 (en) * | 1990-03-14 | 1990-05-09 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-01-28 GB GB929201751A patent/GB9201751D0/en active Pending
-
1993
- 1993-01-26 MX MX9300406A patent/MX9300406A/es unknown
- 1993-01-26 ZA ZA93549A patent/ZA93549B/xx unknown
- 1993-01-27 EP EP93902470A patent/EP0625981A1/en not_active Withdrawn
- 1993-01-27 WO PCT/GB1993/000174 patent/WO1993015080A1/en not_active Application Discontinuation
- 1993-01-27 AU AU33645/93A patent/AU3364593A/en not_active Abandoned
- 1993-01-27 JP JP5513048A patent/JPH07503462A/ja active Pending
- 1993-01-27 CA CA002128536A patent/CA2128536A1/en not_active Abandoned
-
1994
- 1994-07-27 KR KR1019940702589A patent/KR950700305A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0625981A1 (en) | 1994-11-30 |
AU3364593A (en) | 1993-09-01 |
CA2128536A1 (en) | 1993-08-05 |
GB9201751D0 (en) | 1992-03-11 |
JPH07503462A (ja) | 1995-04-13 |
ZA93549B (en) | 1994-09-22 |
MX9300406A (es) | 1994-07-29 |
WO1993015080A1 (en) | 1993-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA93550B (en) | Azabricyclic compounds as calcium channel antagonists | |
NO943140D0 (no) | Heterobicykliske forbindelser | |
DE69315913D1 (de) | Kautschukmischungen | |
DE69216347T3 (de) | Polyolefinzusammensetzung | |
AU3364493A (en) | Compounds as calcium channel antagonists | |
BG96392A (bg) | Химически съединения | |
DK0569013T3 (da) | Quinolinforbindelser som angiotensin II antagonister | |
BR9201427A (pt) | Soli misturador | |
DE69421475T2 (de) | Gemischbildungsvorrichtung | |
ZA949291B (en) | Isoxazoline compounds useful as fibrinogen receptor antagonists | |
DE69313922T2 (de) | Polypropylene-Copolyphthalamid Zusammensetzungen | |
EP0714295A4 (ko) | ||
KR950700305A (ko) | 칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists) | |
DK33392A (da) | Etgrebsblandingsarmatur | |
DE69327589T2 (de) | Wasserabdichtungsbahn | |
NO924112L (no) | Acetylenforbindelser | |
DK1890D0 (da) | Goedningsblanding | |
FI945907A0 (fi) | Kemiallisia yhdisteitä | |
BR1100413A (pt) | Compostos de dissulfonil metano | |
ZA948232B (en) | Amine derivatives as calcium channel antagonists | |
FI943359A (fi) | Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina | |
FI934801A0 (fi) | Kalciumkanalblockerande polypeptider haerstammande fraon spindeln heteropoda venatoria | |
DE69120860D1 (de) | Stabilisierte Polyolefin-Zusammensetzung | |
FI94U1 (fi) | Kompostor | |
LV10286A (lv) | Peptidu savienojumi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |